UCB - Market Capitalization

Stock Price
264.50
Daily Change
-3.30 -1.23%
Monthly
4.59%
Yearly
64.44%
Q2 Forecast
257.81

UCB reported EUR50.19B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 31.08B 1.97B Dec/2025
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
argenx SE USD 51.83B 7.52B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
Galapagos EUR 1.85B 76.44M Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 53.3B 5.72B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Orion EUR 8.94B 243.74M Dec/2025
Recordati EUR 10.15B 660.84M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 46.41B 13.94B Dec/2025
Unibail Rodamco EUR 13.3B 1.68B Dec/2025